Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:AKRX

Akorn (AKRX) Stock Price, News & Analysis

Akorn logo

About Akorn Stock (NASDAQ:AKRX)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.09
$0.32
52-Week Range
N/A
Volume
1.19 million shs
Average Volume
9.60 million shs
Market Capitalization
$3.60 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AKRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Akorn and its competitors with MarketBeat's FREE daily newsletter.

AKRX Stock News Headlines

Akorn Reaches New 52-Week High (AKRX)
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
See More Headlines

AKRX Stock Analysis - Frequently Asked Questions

Akorn, Inc. (NASDAQ:AKRX) announced its earnings results on Monday, May, 11th. The company reported $0.36 EPS for the quarter, beating analysts' consensus estimates of ($0.09) by $0.45. The company earned $204.69 million during the quarter, compared to the consensus estimate of $168.90 million. Akorn had a positive trailing twelve-month return on equity of 8.53% and a negative net margin of 55.64%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Akorn investors own include Bristol Myers Squibb (BMY), Integrated Device Technology (IDTI), Skechers U.S.A. (SKX), Rite Aid (RAD), Lannett (LCI), Bank of America (BAC) and Quantenna Communications (QTNA).

Company Calendar

Last Earnings
5/11/2020
Today
7/09/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:AKRX
CIK
3116
Fax
N/A
Employees
2,227
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$226.77 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$682.43 million
Price / Cash Flow
0.19
Book Value
$1.86 per share
Price / Book
N/A

Miscellaneous

Free Float
N/A
Market Cap
$3.60 million
Optionable
Optionable
Beta
0.95
Beginner's Guide To Retirement Stocks Cover

Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

This page (NASDAQ:AKRX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners